Clinical trial
Phase I/II Trial of Radiotherapy in Combination With Atezolizumab Prior to Surgical Resection for HPV-unrelated Squamous Cell Carcinoma of the Head and Neck (HNSCC)
NCT05053737 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I/II Trial of Radiotherapy in Combination With Atezolizumab Prior to Surgical Resection for HPV-unrelated Squamous Cell Carcinoma of the Head and Neck (HNSCC)
- Lead sponsor
- University of Colorado, Denver
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 2, 2021
- Completion date
- June 21, 2024
- Enrollment
- 11 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.